Beall G N, Rapoport B, Chopra I J, Kruger S R
Int Arch Allergy Appl Immunol. 1986;81(4):351-6. doi: 10.1159/000234162.
We immunized rabbits with human (h) or bovine (b) thyroid-stimulating hormone (TSH), hTSH beta chains or human serum albumin. Serum from the rabbits was then assayed for thyroid-stimulating activity, using the thyroid-cell bioassay. Anti-idiotypic antibodies (anti-ID) to monoclonal anti-TSH were detected in these rabbit antisera after removal of rheumatoid factor by absorption with IgG. Anti-ID activity was detected in the serum of the rabbits immunized with bovine TSH. Thyroid-stimulating antibody (TSI) activity, too, was most prominent in the sera obtained from bTSH-immunized rabbits. Anti-ID activity seemed to arise sooner than did TSI, but both tended to peak 3 months after an initial series of immunizations. Since thyroid-stimulating immunoglobulins can develop following TSH immunization of rabbits, it is possible that a similar immunopathogenesis may be responsible for some instances of Graves' hyperthyroidism.
我们用人类(h)或牛(b)促甲状腺激素(TSH)、hTSHβ链或人血清白蛋白免疫兔子。然后,使用甲状腺细胞生物测定法检测兔子血清中的促甲状腺活性。在用IgG吸收去除类风湿因子后,在这些兔抗血清中检测到针对单克隆抗TSH的抗独特型抗体(抗ID)。在用牛TSH免疫的兔子血清中检测到抗ID活性。促甲状腺抗体(TSI)活性在从bTSH免疫的兔子获得的血清中也最为显著。抗ID活性似乎比TSI出现得更早,但两者在初次免疫系列后的3个月都趋于达到峰值。由于兔子经TSH免疫后可产生促甲状腺免疫球蛋白,因此类似的免疫发病机制可能是某些格雷夫斯甲亢病例的病因。